Related Experiment Video
Updated: Mar 9, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Modulation of Cytotoxicity by Transcription-Coupled Nucleotide Excision Repair Is Independent of the Requirement for
Claudia Otto1, Graciela Spivak2, Claudia M N Aloisi1
1Department of Health Sciences and Technology, ETH Zurich , 8092 Zurich, Switzerland.
Abstract:
Bioactivation as well as DNA repair affects the susceptibility of cancer cells to the action of DNA-alkylating chemotherapeutic drugs. However, information is limited with regard to the relative contributions of these processes to the biological outcome of metabolically activated DNA alkylating agents. We evaluated the influence of cellular bioactivation capacity and DNA repair on cytotoxicity of the DNA alkylating agent acylfulvene (AF). We compared the cytotoxicity and RNA synthesis inhibition by AF and its synthetic activated analogue iso-M0 in a panel of fibroblast cell lines with deficiencies in transcription-coupled (TC-NER) or global genome nucleotide excision repair (GG-NER). We related these data to the inherent bioactivation capacity of each cell type on the basis of mRNA levels. We demonstrated that specific inactivation of TC-NER by siRNA had the largest positive impact on AF activity in a cancer cell line. These findings establish that transcription-coupled DNA repair reduces cellular sensitivity to AF, independent of the requirement for bioactivation.
Insights
Transcription-coupled DNA repair reduces cancer cell sensitivity to DNA alkylating agents like acylfulvene, regardless of bioactivation. This DNA repair pathway significantly impacts drug efficacy.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Cellular susceptibility to DNA alkylating chemotherapeutic drugs is influenced by bioactivation and DNA repair.
- The specific roles of these processes in the biological outcomes of metabolically activated DNA alkylating agents are not fully understood.
Purpose of the Study:
- To evaluate the impact of cellular bioactivation capacity and DNA repair on the cytotoxicity of the DNA alkylating agent acylfulvene (AF).
- To compare the cytotoxicity and RNA synthesis inhibition by AF and its analogue iso-M0 in cell lines with deficiencies in specific DNA repair pathways.
Main Methods:
- Utilized a panel of fibroblast cell lines with deficiencies in transcription-coupled nucleotide excision repair (TC-NER) or global genome nucleotide excision repair (GG-NER).
- Assessed cytotoxicity and RNA synthesis inhibition following treatment with AF and iso-M0.
- Related experimental data to the inherent bioactivation capacity of each cell type using mRNA levels.
- Employed siRNA to specifically inactivate TC-NER.
Main Results:
- Specific inactivation of TC-NER by siRNA significantly increased AF activity in a cancer cell line.
- Cellular sensitivity to AF was reduced by transcription-coupled DNA repair.
- This effect was observed independently of the requirement for bioactivation.
Conclusions:
- Transcription-coupled DNA repair plays a crucial role in determining cellular sensitivity to acylfulvene.
- Targeting or understanding TC-NER could be a strategy to enhance the efficacy of DNA alkylating agents in cancer therapy.
- The findings highlight the importance of DNA repair mechanisms in drug response.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
The Extrinsic Apoptotic Pathway
Long-patch Base Excision Repair
Bioactivation and Tissue Toxicity
Base Excision Repair
The first step of...

